Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Gabapentin
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
====United States==== Gabapentin is not a controlled substance under the federal [[Controlled Substances Act]].<ref>{{cite web|url=https://www.deadiversion.usdoj.gov/drug_chem_info/gabapentin.pdf|publisher=Drug Enforcement Administration|title=Gabapentin (Neurontin)|date=January 2023}}</ref> Effective 1 July 2017, Kentucky classified gabapentin as a [[Controlled Substances Act#Schedules of controlled substances|schedule V controlled substance]] statewide.<ref>{{cite web|url=https://pharmacy.ky.gov/Documents/Gabapentin%20-%20Schedule%20V%20Controlled%20Substance.pdf|title=Important Notice: Gabapentin Becomes a Schedule 5 Controlled Substance in Kentucky |date=March 2017|website=Kentucky State Board of Pharmacy |access-date=18 June 2018}}</ref> Gabapentin is scheduled V drug in other states such as West Virginia,<ref>{{cite web|title=WV Code 212|url=http://www.wvlegislature.gov/WVCODE/ChapterEntire.cfm?chap=60a&art=2§ion=212|website=West Virginia Legislature |access-date=30 May 2020}}</ref> Tennessee,<ref>{{cite web|title=Gabapentin will be a Schedule V controlled substance in Tennessee effective July 1, 2018|url=https://www.tn.gov/content/dam/tn/health/healthprofboards/New%20Statue%20Gabapentin%2006-18.pdf|website=tn.gov|access-date=30 May 2020}}</ref> Alabama,<ref>{{cite web|title=Pharmacy Division |url=http://www.alabamapublichealth.gov/pharmacy/|website=Alabama Department of Public Health (ADPH) |access-date=30 May 2020}}</ref> Utah,<ref>{{cite web|title=Controlled Substances Amendments |url=https://le.utah.gov/~2024/bills/static/HB0260.html|website=Utah State Legislature |access-date=12 April 2024}}</ref> and Virginia.<ref>{{cite web|url=http://www.dhp.virginia.gov/Pharmacy/docs/gabapentin06172019.pdf|title=Scheduling of Gabapentin|access-date=28 June 2023|publisher=Virginia Department of Health Professions}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)